|
The FDA is working overtime to approve drugs.
|
8
|
Resverlogix Corp.
|
Feb 01, 2020 02:43PM
|
|
Re: Apabetalone publication in "Current Opinion in Nephrology & Hypertension"
|
4
|
Resverlogix Corp.
|
Jan 30, 2020 08:44AM
|
|
Apabetalone publication in "Current Opinion in Nephrology & Hypertension"
|
6
|
Resverlogix Corp.
|
Jan 29, 2020 04:42PM
|
|
Re: Pfizer's plans for research: sounds like RVX!
|
8
|
Resverlogix Corp.
|
Jan 29, 2020 12:09PM
|
|
Pfizer's plans for research: sounds like RVX!
|
10
|
Resverlogix Corp.
|
Jan 29, 2020 11:45AM
|
|
Re: Hepalink IPO Document and what it says about RVX
|
6
|
Resverlogix Corp.
|
Jan 27, 2020 07:21AM
|
|
Hepalink IPO Document and what it says about RVX
|
8
|
Resverlogix Corp.
|
Jan 26, 2020 03:59PM
|
|
Question about Zenith
|
3
|
Resverlogix Corp.
|
Jan 24, 2020 06:17PM
|
|
Re: Hepa is up over 7% in early trading ...
|
4
|
Resverlogix Corp.
|
Jan 22, 2020 10:57PM
|
|
Re: Eli Lilly CFO Comment
|
8
|
Resverlogix Corp.
|
Jan 19, 2020 08:23PM
|
|
Eli Lilly CFO Comment
|
7
|
Resverlogix Corp.
|
Jan 18, 2020 03:23PM
|
|
Re: Looks like Top SoC for Diabetes is evolving yet again:
|
2
|
Resverlogix Corp.
|
Jan 17, 2020 07:54PM
|
|
Re: Biotech Showcase, Jan 13-15
|
3
|
Resverlogix Corp.
|
Jan 12, 2020 11:36AM
|
|
Re: Biotech Showcase, Jan 13-15
|
4
|
Resverlogix Corp.
|
Jan 12, 2020 07:20AM
|
|
Re: Biotech Showcase, Jan 13-15
|
3
|
Resverlogix Corp.
|
Jan 11, 2020 02:46PM
|
|
Re: Nice run for Hepa over the holidays
|
3
|
Resverlogix Corp.
|
Jan 06, 2020 01:17PM
|
|
Re: Nice run for Hepa over the holidays
|
4
|
Resverlogix Corp.
|
Jan 06, 2020 09:33AM
|
|
Breakthrough Therapy Question
|
1
|
Resverlogix Corp.
|
Jan 05, 2020 02:36PM
|
|
Re: The last couple of minutes of Tax Loss Selling
|
1
|
Resverlogix Corp.
|
Dec 30, 2019 12:03PM
|
|
Re: The last couple of minutes of Tax Loss Selling
|
1
|
Resverlogix Corp.
|
Dec 30, 2019 10:56AM
|
